NAPSIN A (NAPSA) (NM_004851) Human Recombinant Protein

CAT#: TP762393

Purified recombinant protein of Human napsin A aspartic peptidase (NAPSA), Arg107-End, with N-terminal His tag, expressed in E.coli, 50ug

Product Images

Purified recombinant protein NAPSA was analyzed by SDS-PAGE gel and Coomossie Blue Staining.

Specifications

Product Data

• Species: Human
• Expression Host: E. coli
• Expression cDNA Clone or AA Sequence:
  Protein Sequence

  A DNA sequence encoding the region (Arg107-End) of NAPSA
• Tag: N-His
• Predicted MW: 33.8 kDa
• Concentration: >50 ug/mL as determined by microplate BCA method
• Purity: >80% as determined by SDS-PAGE and Coomassie blue staining
• Buffer: 50mM Tris, pH8.0, 8M Urea
• Storage: Store at -80°C after receiving vials.
• Stability: Stable for at least 1 year from receipt of products under proper storage and handling conditions. Avoid repeated freeze-thaw cycles.

Reference Data

• RefSeq: NP_004842
• Locus ID: 9476
• UniProt ID: O96009
• Cytogenetics: 19q13.33
• Refseq Size: 1438
• Refseq ORF: 1260
• Synonyms: KAP; Kdap; NAP1; NAPA; SNAPA
• Summary: This gene encodes a member of the peptidase A1 family of aspartic proteases. The encoded preproprotein is proteolytically processed to generate an activation peptide and the mature protease. The activation peptides of aspartic proteinases function as inhibitors of the protease active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The encoded protease may play a role in the proteolytic processing of pulmonary surfactant protein B in the lung and may function in protein catabolism in the renal proximal tubules. This gene has been described as a marker for lung adenocarcinoma and renal cell carcinoma. [provided by RefSeq, Feb 2016]
• Protein Families: Druggable Genome, Protease
• Protein Pathways: Lysosome